Author:
Mets Sarah,Tryon Rebecca,Veach Patricia McCarthy,Zierhut Heather A.
Reference56 articles.
1. Alter, B. P., Rosenberg, P. S., & Brody, L. C. (2007). Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2. Journal of Medical Genetics, 44(1), 1–9. doi: 10.1136/jmg.2006.043257
2. American College of Obstetricians and Gynocologists. (2011). Committee Opinion: Update on carrier screening for cystic fibrosis. Opinion 486. Retrieved from https://www.acog.org/~/media/Committee Opinions/Committee on Genetics/co486.pdf?dmc = 1&ts = 20140721 T1321334730
3. Association for Molecular Pathology v. Myriad Genetics. (2013). Retrieved from https://www.aclu.org/files/assets/12-398_8njq.pdf
4. Berliner, J. L., Fay, A. M., Cummings, S. A., Burnett, B., & Tillmanns, T. (2013). NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer,". Journal of Genetic Counseling, 22(2), 155–163.
5. Berwick, M., Satagopan, J. M., Ben-Porat, L., Carlson, A., Mah, K., Henry, R., et al. (2007). Genetic heterogeneity among fanconi anemia heterozygotes and risk of cancer. Cancer Research, 67(19), 9591–9596. doi: 10.1158/0008-5472.CAN-07-1501 .
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献